| Literature DB >> 17627580 |
Seiichiro Ogawa1, Miki Kanto, Yoshiyuki Suzuki.
Abstract
This article reviews synthesis and structures of carbaglycosylamines, a group of carbocyclic sugar analogues. Some unsaturated derivatives are known to be potent glycosidase inhibitors. Among them, N-octyl-4-epi-beta-valienamine as a lysosomal beta-galactosidase inhibitor is currently undergoing a new molecular therapeutic trial (chemical chaperone therapy) for control of the human beta-galactosidase deficiency disorder, G(M1)-gangliosidosis.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17627580 DOI: 10.2174/138955707781024508
Source DB: PubMed Journal: Mini Rev Med Chem ISSN: 1389-5575 Impact factor: 3.862